about
Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer.Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer.Clinicopathologic Similarities of the Main and Minor Lesions of Synchronous Multiple Early Gastric Cancer.Risk Factors for Metachronous Recurrence after Endoscopic Submucosal Dissection of Early Gastric Cancer.Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.The efficacy of self-expanding metal stents for colorectal obstruction with unresectable stage IVB colorectal cancer.[Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].Endoscopic botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunctionEffect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study
P50
Q33381016-EB55E083-8BDC-4D3F-A64C-1916831AB60FQ33395417-33983CD5-4ABC-4712-A137-BFF007F9DE65Q36859830-C801AF8D-E369-488E-B4F8-D5A970336003Q37622302-C8DD4AF0-D45A-44B9-90B0-4F7A9AF8ACEFQ41017557-A4C7BC1C-2E0D-4E82-8787-3EF6E3FEDDECQ51346893-5D7222C3-1281-47F8-9B10-0205D1595C45Q53370310-E1DAE96D-BB9B-46B1-A632-7832F8907990Q57794553-3C9FE619-BCB1-4DAE-AF64-EE6A41BDA68BQ91951950-7001337B-ACC2-4D02-8111-0D314577B5D3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yoon Jae Kim
@ast
Yoon Jae Kim
@en
Yoon Jae Kim
@es
Yoon Jae Kim
@sl
type
label
Yoon Jae Kim
@ast
Yoon Jae Kim
@en
Yoon Jae Kim
@es
Yoon Jae Kim
@sl
prefLabel
Yoon Jae Kim
@ast
Yoon Jae Kim
@en
Yoon Jae Kim
@es
Yoon Jae Kim
@sl
P1053
G-6633-2015
P106
P1153
55702100300
P31
P3829
P496
0000-0001-8477-6823